Malawista Stephen E, de Boisfleury Chevance Anne, Brown Eric J, Boxer Laurence A, Law S K A
Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut 06520, USA.
Am J Hematol. 2003 Jun;73(2):115-20. doi: 10.1002/ajh.10311.
We have defined the defect in a child with severe leukocyte adhesion deficiency-1 (LAD) as resulting from a single amino acid shift in CD18 (from a C to T mutation at position 533) that prevents heterodimerization with the CD11 antigens to produce beta(2) integrins-the first reported patient homozygous for this defect. Although beset by frequent infections, the patient has survived to adolescence despite the lack of these important adhesion molecules. Consistent with his clinical course is the ability of his PMN to respond chemotactically in slide preparations, albeit with difficulty because of their poor purchase on substrate. The operant adhesins are unknown; his polymorphonuclear leukocytes (PMN) remain chemotactically responsive in the presence of antibodies to alphavbeta(3) and beta(1) integrins and to integrin-associated protein (IAP). These findings indicate that not all patients with severe LAD are candidates for early bone marrow transplantation.
我们已确定一名患有严重白细胞黏附缺陷-1(LAD)的儿童的缺陷是由CD18中的单个氨基酸移位(第533位从C突变为T)导致的,该移位阻止了与CD11抗原形成异二聚体以产生β2整合素——这是首例报道的该缺陷纯合子患者。尽管该患者频繁感染,但尽管缺乏这些重要的黏附分子,他仍存活至青春期。与他的临床病程一致的是,他的中性粒细胞在玻片制备中能够进行趋化反应,尽管由于它们在底物上的附着性差而存在困难。起作用的黏附素尚不清楚;在存在抗αvβ3和β1整合素以及整合素相关蛋白(IAP)的抗体时,他的多形核白细胞(PMN)仍具有趋化反应性。这些发现表明,并非所有严重LAD患者都是早期骨髓移植的候选者。